MDT stock price:$104.181.38%At close on August 19th, 2019
Updated on: August 19th, 2019
5
Medtronic inched 1.38% to $104.18 after marking all time highs yesterday. Monday was the third green day in a row, marking 3.17%.
Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide.
Should I buy Medtronic stock?
Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks.Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them.At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, 2 buy setups are elegible for Medtronic stock now:
Buy setup
Elegible
New all-time high
Yes
New 52 week high
Yes
Price crossing up 200d MA
No
100d MA crossing up 200d MA
No
Is Medtronic stock a buy?
Financial institutions and banks post stock ratings everyday.
At Stocks2.com, we collected 15 ratings published for MDT stock in the last 30 days.The general sentiment of these ratings is bullish for MDT stock, with 7 positive ratings.
Is MDT a good stock to buy?
Date
Analyst / Broker
Previous rating
Current rating
2019-8-19
Deutsche Bank
n/a
Buy
2019-8-16
Royal Bank of Canada
n/a
Outperform
2019-8-14
Morgan Stanley
n/a
Equal Weight
2019-8-14
Cowen
n/a
Outperform
2019-7-23
Needham & Company LLC
n/a
Buy
2019-7-11
Barclays
n/a
Overweight
2019-6-20
Northland Securities
n/a
Hold
2019-6-14
UBS Group
n/a
Buy
2019-4-4
Wells Fargo & Co
Market Perform
Market Perform
2019-3-18
Northland Securities
n/a
Hold
2019-2-4
Needham & Company LLC
Strong-Buy
Strong-Buy
2019-2-4
Needham & Company LLC
n/a
Strong-Buy
2019-1-8
Barclays
Overweight
Overweight
2019-1-2
Morgan Stanley
Equal Weight
Equal Weight
2019-1-2
Citigroup
Buy
Neutral
Medtronic stock analysis
Daily outlook
Medtronic inched 1.38% to $104.18 after reaching all time highs yesterday.
Medtronic inched 1.38% yesterday and reached a new all time high at $104.43. On July, SMA100d and SMA200d crossed up triggering a rise of 7.56%. Since last May when MDT stock price broke up the SMA200d line, it gained $15.91 (18.02%).
MDT stock chart (daily)
Weekly outlook
Shares of Medtronic closed this week at $104.18 after topping to a new all time high ($104.43) and raised a slightly good 1.38%.
MDT shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom early August, MDT climbed unceasignly breaking out to new all time highs. Since SMA20d and SMA40w crossed up late June, MDT price climbed $5.34 per share (5.40%). Since late May when MDT stock price broke up the SMA40w line, it gained $16.93 (19.40%).
MDT stock chart (weekly)
Medtronic stock price history
Medtronic stock historical price chart
MDT stock reached all-time highs yesterday with a price of $104.43.
Medtronic stock price target is $105.60
Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we found 14 price forecasts for Medtronic stock:
MDT stock price predictions
Date
Analyst / Broker
Action
Previous target
Current target
Diff
2019-8-19
Deutsche Bank
Reiterates
$100.00
$111.00
11%
2019-8-16
Royal Bank of Canada
Raises Target
n/a
$110.00
-
2019-8-14
Morgan Stanley
Raises Target
$100.00
$105.00
5%
2019-8-14
Cowen
Reiterates
$99.00
$111.00
12.1%
2019-7-11
Barclays
Raises Target
$104.00
$110.00
5.8%
2019-6-20
Northland Securities
Reiterates
n/a
$100.00
-
2019-6-14
UBS Group
Raises Target
n/a
$112.00
-
2019-4-4
Wells Fargo & Co
Lowers Target
$101.00
$100.00
-1%
2019-3-18
Northland Securities
Reiterates
n/a
$84.00
-
2019-2-4
Needham & Company LLC
Reiterates
$120.00
$117.00
-2.5%
2019-2-4
Needham & Company LLC
Lowers Target
$120.00
$117.00
-2.5%
2019-1-8
Barclays
Lowers Target
$113.00
$104.00
-8%
2019-1-2
Morgan Stanley
Raises Target
$98.00
$102.00
4.1%
2019-1-2
Citigroup
Downgrades
$109.00
$96.00
-11.9%
(in average)
$106.40
$105.60
-1.0%
The price prediction for Medtronic stock is $105.60, moving in a range between $117.00 and $84.00. In average, analysts' outlook on MDT price target is stable from previous estimations.
Financials and fundamental analysis
Earnings date and Earnings per Share
On February, Medtronic presented its financial report, posting a tiny climb for the Earnings per Share (EPS) ratio. Analyst were expecting $1.24 per share, but Medtronic posted $1.29.
MDT earnings date and EPS evolution
Quarter
Reporting date
Estimated EPS
Actual EPS
Surprise
2017-Q2
-
n/a
n/a
n/a
2017-Q3
-
n/a
n/a
n/a
2017-Q4
-
n/a
n/a
n/a
2018-Q1
2018-02-20
1.16
1.17
0.9%
2018-Q2
2018-05-24
1.38
1.42
2.9%
2018-Q3
2018-08-21
1.11
1.17
5.4%
2018-Q4
2018-11-20
1.14
1.22
7.0%
2019-Q1
2019-02-19
1.24
1.29
4.0%
2019-Q2
-
n/a
n/a
n/a
2019-Q3
-
n/a
n/a
n/a
Annual financial results
In 2018, Medtronic annual sales stayed constant a tight 0.01% to $29,953.00 million USD from $29,950.00 marked in 2018.Aligned with this, its income margin (compared to sales) remained stable to 10.36%, that is $3,104.00 million.To have an updated picture of the financial situation of Medtronic, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Medtronic TTM sales up to January 2019 were $30,555.00 and earnings were $4,919.00 M dollars.If we compare this TTM figures with the last reported annuality, we can review Medtronic business evolution since April 2018: Annual sales up to January, compared to lastest yearly report, grew a tiny 2.01%.In line, profit margin (net income/sales) escalated at 10.36%.
MDT annual Sales and Income evolution
Year
Sales
YoY
Income/(margin)
YoY
2014
$17,010 M
-
$3,070 M18.0%
-
2014
$17,010 M
0.00%
$3,070 M18.0%
0.00%
2015
$20,260 M
19.11%
$2,680 M13.2%
-12.70%
2015
$20,261 M
0.00%
$2,675 M13.2%
-0.19%
2016
$28,830 M
42.29%
$3,540 M12.3%
32.34%
2016
$28,833 M
0.01%
$3,538 M12.3%
-0.06%
2017
$29,710 M
3.04%
$4,030 M13.6%
13.91%
2017
$29,710 M
0.00%
$4,028 M13.6%
-0.05%
2018
$29,950 M
0.81%
$3,100 M10.4%
-23.04%
2018
$29,953 M
0.01%
$3,104 M10.4%
0.13%
TTM
$30,555 M
2.01%
$4,919 M16.1%
58.47%
Quarterly financial results
Medtronic reported $7,546.00 M in revenues for 2019-Q1, a 0.87% improvement compared to previous quarter.Reported quarter income marked $1,269.00 M with a profit margin of 16.82%. Profit margin stepped up a 1.91% compared to previous quarter when profit margin was 14.90%.When comparing sales to same quarter last year, Medtronic sales marked a slightly fine growth and raised a 2.40%.Looking back to recent quarterly results, Medtronic posted 2 negative quarters in a row.
MDT quarterly Sales and Income evolution
Quarter
Sales1
QoQ2
Income1/(margin)
QoQ2
2017-Q2
$7,920 M
-
$1,160 M14.6%
-
2017-Q3
$7,390 M
-6.69%
$1,020 M13.8%
-12.07%
2017-Q4
$7,050 M
-4.60%
$2,017 M28.6%
97.75%
2018-Q1
$7,369 M
4.52%
$-1,389 M-18.8%
-168.86%
2018-Q2
$8,144 M
10.52%
$1,460 M17.9%
-205.11%
2018-Q3
$7,384 M
-9.33%
$1,075 M14.6%
-26.37%
2018-Q4
$7,481 M
1.31%
$1,115 M14.9%
3.72%
2019-Q1
$7,546 M
0.87%
$1,269 M16.8%
13.81%
Medtronic ownership
When you are planning to buy a stock, it's worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Medtronic, 0.06% of all outstanding shares are owned by its staff.
Bearish positions for MDT stock account 0.00%, no big difference from last month.
For a better context understanding, the next table shows ownership data compared to other related companies:
MDT
ABT
BAX
BSX
CNMD
Market cap
$0.0 M
$150.6 B
$44.8 B
$59.4 B
$2.7 B
Total shares
0.0 M
1,760.0 M
510.2 M
1,390.0 M
28.3 M
Float shares
1,340.0 M
1,750.0 M
509.5 M
1,390.0 M
27.6 M
- Institutional holdings (%)
84.2%
76.5%
88.2%
93.4%
97.5%
- Insider holdings (%)
0.1%
0.7%
0.1%
0.2%
1.8%
Shares in short selling
0.0%
0.0%
0.0%
0.0%
0.0%
Medtronic summary
Monday, August 19th, 2019
Open
$103.50
Close
$104.18
Day range
$103.02 - $104.43
Previous close
$102.76
Session gain
1.38%
Average true range
$2.01
50d mov avg
$99.88
100d mov avg
$94.32
200d mov avg
$92.00
Daily pattern
lt02a
Weekly pattern
lb03c
Medtronic performance
To measure stock performance is always good to compare with competitors or related stocks. We compared Medtronic against , Baxter International, Boston Scientific, CONMED, Edwards Lifesciences, Integra LifeSciences, , Owens & Minor, Stryker and Zimmer Biomet in the following table:
Stock
3m
6m
12m
MDTMedtronic
12.60%
12.32%
11.42%
ABT
11.57%
13.26%
31.61%
BAXBaxter Internatio...
17.33%
18.30%
22.76%
BSXBoston Scientific
11.07%
5.45%
23.07%
CNMDCONMED
18.87%
28.08%
25.38%
EWEdwards Lifescien...
31.36%
28.98%
56.99%
IARTIntegra LifeScien...
25.88%
12.30%
4.07%
JNJ
-4.75%
-1.88%
-0.12%
OMIOwens & Minor
42.53%
-22.14%
-69.40%
SYKStryker
18.15%
16.75%
29.11%
ZBHZimmer Biomet
21.25%
11.80%
11.40%
Medtronic competitors
One check before trading any stock is to review a list of its competitors, in this case for Medtronic. We picked 10 companies as Medtronic competitors as they are in the same industry or have similar market objectives.